The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Effectiveness of Primary Care–Relevant Treatments for Obesity in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force
Abstract
BACKGROUND: Overweight and obesity in adults are common and adversely affect health. PURPOSE: To summarize effectiveness and harms of primary care-relevant weight-loss interventions for overweight and obese adults. DATA SOURCES: MEDLINE, Cochrane Central Register of Controlled Trials, and PsycINFO from January 2005 to September 2010; systematic reviews for identifying trials before 2005. STUDY SELECTION: Two investigators appraised 6498 abstracts and 648 articles. Clinical trials were included if control groups received minimal interventions. Articles were rated as good, fair, or poor by using design-specific criteria. DATA EXTRACTION: One investigator abstracted study characteristics and findings for good- and fair-quality studies; a second checked them. DATA SYNTHESIS: Behaviorally based treatment resulted in 3-kg (6.6-lb) greater weight loss in intervention than control participants after 12 to 18 months, with more treatment sessions associated with greater loss. Limited data suggest weight-loss maintenance for 1 year or more. Orlistat plus behavioral intervention resulted in 3-kg (6.6-lb) more weight loss than did placebo after 12 months. Metformin resulted in less weight loss. Data on effects of weight-loss treatment on long-term health outcomes (for example, death and cardiovascular disease) were insufficient. Weight-loss treatment reduced diabetes incidence in participants with prediabetes. Effects on intermediate outcomes (for example, lipids and blood pressure) were mixed and small. Data on serious medication harms were insufficient. Medications commonly caused withdrawals due to gastrointestinal symptoms. LIMITATIONS: Few studies reported health outcomes. Behaviorally based treatments were heterogeneous and specific elements were not well-described. Many studies could not be pooled because of insufficient reporting of variance data. Medication trials had high attrition, lacked postdiscontinuation data, and were inadequately powered for rare adverse effects. CONCLUSION: Behaviorally based treatments are safe and effective for weight loss and maintenance. PRIMARY FUNDING SOURCE: Agency for Healthcare Research and Quality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 2×
“…2009 (57) Woollard et al, 2003 (64) Cohen et al, 1991 (32) Langford et al, 1985 (DISH) (43) Burke et al, 2005 (ADAPT) (30) Mensink et al, 2003 (46) Tuomilehto et al, 2001 (FDPS) (58) Parikh et al, 2010 (Project HEED) (49) Kulzer et al, 2009 (PREDIAS) (42) Stevens et al, 1993 (TOHP-I) (54) DPP,…”
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Guh, D. P., Zhang, W., Bansback, N., Amarsi, Z., Birmingham, C. L., & Anis, A. H. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-88 · Cited by 3,855
Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults
Calle, E. E., Thun, M. J., Petrelli, J. M., Rodriguez, C., & Heath, C. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910073411501 · Cited by 3,643
General and abdominal adiposity and risk of death in Europe
Pischon, T., Boeing, H., Hoffmann, K., Bergmann, M., Schulze, M. B., Overvad, K., van der Schouw, Y. T., Spencer, E., Moons, K. G. M., Tjønneland, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801891 · Cited by 2,155
Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients
Christou, N. V., Sampalis, J. S., Liberman, M., Look, D., Auger, S., McLean, A. P. H., & MacLean, L. D. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000137343.63376.19 · Cited by 1,288
Lee, C. M. Y., Huxley, R. R., Wildman, R. P., & Woodward, M. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.08.012 · Cited by 1,173
(2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.334 · Cited by 1,162
Vazquez, G., Duval, S., Jacobs, D. R., & Silventoinen, K. (2007) · Epidemiologic Reviews · doi:10.1093/epirev/mxm008 · Cited by 976
Davidson, M. H., Hauptman, J., DiGirolamo, M., Foreyt, J. P., Halsted, C. H., Heber, D., Heimburger, D. C., Lucas, C. P., Robbins, D. C., Chung, J., et al. (1999) · JAMA · doi:10.1001/jama.281.3.235 · Cited by 947 · cited 4×
“…and Sachse, 2002 (71) Miles et al, 2002 (77) Derosa et al, 2010 (69) Swinburn et al, 2005 (81) Hollander et al, 1998 (74) Broom et al, 2002 (66) Davidson et al, 1999 (67) Rössner et al, 2000 (79) Hauptman et al, 2000 (72) Krempf et al, 2003 (75) Subtotal (I 2 = 84.9%; P =…”
InfluentialStevens, V. J., Obarzanek, E., Cook, N. R., Lee, I.-M., Appel, L. J., Smith West, D., Milas, N. C., Mattfeldt-Beman, M., Belden, L., Bragg, C., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-1-200101020-00007 · Cited by 886 · cited 7×
“Stevens et al, 1993 (TOHP-I) (54) DPP, 2005 (85) Stevens et al, 2001 (TOHP-II) (55) Haapala et al, 2009 (37) Werkman et al, 2010 (60) Martin et al, 2008 (44) Simkin-Silverman et al, 2003 (WHLP) (53) Wood et al, 1988 (62)”
BackgroundInfluentialWood, P. D., Stefanick, M. L., Dreon, D. M., Frey-Hewitt, B., Garay, S. C., Williams, P. T., Superko, H. R., Fortmann, S. P., Albers, J. J., Vranizan, K. M., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811033191801 · Cited by 675
Hollander, P. A., Elbein, S. C., Hirsch, I. B., Kelley, D., McGill, J., Taylor, T., Weiss, S. R., Crockett, S. E., Kaplan, R. A., Comstock, J., et al. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1288 · Cited by 654
Wood, P. D., Stefanick, M. L., Williams, P. T., & Haskell, W. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108153250703 · Cited by 520
Irwin, M. L., Yasui, Y., Ulrich, C. M., Bowen, D., Rudolph, R. E., Schwartz, R. S., Yukawa, M., Aiello, E., Potter, J. D., & McTiernan, A. (2003) · JAMA · doi:10.1001/jama.289.3.323 · Cited by 517 · cited 12×
“ADAPT Activity, Diet and Blood Pressure Trial; CV cardiovascular; DISH Dietary Intervention to Study Hypertension; DPP Diabetes Prevention Program; FDPS Finnish Diabetes Prevention Study; HEED Help Educate to Eliminate Diabetes; HI intensive intervention; IV intervention; LO brief intervention; NR not reported; ORBIT…”
BackgroundMethodInfluentialSilva, M. N., Vieira, P. N., Coutinho, S. R., Minderico, C. S., Matos, M. G., Sardinha, L. B., & Teixeira, P. J. (2010) · Journal of Behavioral Medicine · doi:10.1007/s10865-009-9239-y · Cited by 448
Orlistat in the long-term treatment of obesity in primary care settings.
Hauptman, J. (2000) · Archives of Family Medicine · doi:10.1001/archfami.9.2.160 · Cited by 367
Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study.
Hill, J. O., Hauptman, J., Anderson, J. W., Fujioka, K., O'Neil, P. M., Smith, D. K., Zavoral, J. H., & Aronne, L. J. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.6.1108 · Cited by 287 · cited 2×
“Orlistat was associated with a decrease in some fat-soluble vitamin levels compared with placebo (73, 74, 79, 82, 99).”
BackgroundResultEffect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin
Miles, J. M., Leiter, L., Hollander, P., Wadden, T., Anderson, J. W., Doyle, M., Foreyt, J., Aronne, L., & Klein, S. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1123 · Cited by 286
The Diabetes Prevention Program Research Group [Prepared by Jill Crandall, D. S. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1075 · Cited by 254 · cited 2×
“Gastrointestinal symptoms were the main reason for excess adverse effects (22, 83, 86, 102).”
BackgroundGambineri, A., Patton, L., Vaccina, A., Cacciari, M., Morselli-Labate, A. M., Cavazza, C., Pagotto, U., & Pasquali, R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2250 · Cited by 221
The Hypertension Prevention Trial: Three-Year Effects of Dietary Changes on Blood Pressure
Hypertension Prevention Trial Research Group (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390130131021 · Cited by 212
Mayer-Davis, E. J., D'Antonio, A. M., Smith, S. M., Kirkner, G., Levin Martin, S., Parra-Medina, D., & Schultz, R. (2004) · American Journal of Public Health · doi:10.2105/ajph.94.10.1736 · Cited by 202 · cited 2×
“When data substitution was used, studies used baseline-observation-carried-forward (33, 37, 38, 42, 52), multiple imputation (35, 56), last-observation-carried-forward (37, 41, 44, 59), imputation of missing data through random-effects regression (35, 45, 64), multiple imputation method (35, 56), or unspecified method…”
BackgroundMethodMaintenance of weight loss in overweight middle-aged women through the Internet
Cussler, E. C., Teixeira, P. J., Going, S. B., Houtkooper, L. B., Metcalfe, L. L., Blew, R. M., Ricketts, J. R., Lohman, J., Stanford, V. A., & Lohman, T. G. (2008) · Obesity · doi:10.1038/oby.2008.19 · Cited by 115
Jones, D. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00123-5 · Cited by 89
Effect of orlistat on cardiovascular disease risk in obese adults
Swinburn, B. A., Carey, D., Hills, A. P., Hooper, M., Marks, S., Proietto, J., Strauss, B. J., Sullivan, D., Welborn, T. A., & Caterson, I. D. (2005) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00467.x · Cited by 81
Cited by
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetologia · doi:10.1007/s00125-018-4729-5 · Cited by 1,455
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
Apovian, C. M., Aronne, L. J., Bessesen, D. H., McDonnell, M. E., Murad, M. H., Pagotto, U., Ryan, D. H., & Still, C. D. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3415 · Cited by 1,347
The science of obesity management: an endocrine society scientific statement
Bray, G. A., Heisel, W. E., Afshin, A., Jensen, M. D., Dietz, W. H., Long, M., Kushner, R. F., Daniels, S. R., Wadden, T. A., Tsai, A. G., et al. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00253 · Cited by 812
Childhood maltreatment and obesity: systematic review and meta-analysis
Danese, A., & Tan, M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.54 · Cited by 709
Metadata
- Authors
- LeBlanc, E. S., O'Connor, E., Whitlock, E. P., Patnode, C. D., & Kapka, T.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2011-10-04
- Volume
- 155
- Issue
- 7
- Pages
- 434-447
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2101802080
- Cited by
- 400
- References
- 28
- FWCI
- 24.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
